CYTOMX THERAPEUTICS INC (CTMX) Institutional Ownership
None of the superinvestors we track currently report CYTOMX THERAPEUTICS INC (CTMX) in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in CYTOMX THERAPEUTICS INC (CTMX), this page will show asset manager ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q3 2025 | 1 | $8,119,379 | 2,545,260 |
| Q2 2025 | 1 | $4,227,194 | 1,862,200 |
| Q1 2025 | 1 | $734,985 | 1,156,000 |
| Q4 2024 | 1 | $1,387,204 | 1,346,800 |
| Q3 2024 | 1 | $1,197,700 | 1,015,000 |
| Q2 2024 | 1 | $1,443,287 | 1,183,022 |
| Q1 2024 | 1 | $2,688 | 1,232,800 |
| Q4 2023 | 1 | $2,055 | 1,325,700 |
| Q3 2023 | 1 | $1,200 | 930,100 |
| Q2 2023 | 1 | $1,931 | 1,122,400 |
| Q1 2023 | 1 | $1,284 | 850,300 |
| Q4 2022 | 1 | $2,145 | 1,340,774 |
Related CTMX Institutional Insights:
- CTMX Institutional Ownership & Insiders Activity
- CTMX Institutional Ownership & 13F Activity
- CTMX Top Institutional Shareholders
- CTMX Institutional Buying Activity
- CTMX Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- CTMX Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings